ADMA amends IPO

ADMA Biologics Inc. (Hackensack, N.J.) amended its IPO and said it plans to sell 2.1 million shares at $13.50-$15.50. A $14.50 price would raise $30.5 million and value the company at $97.5 million. Oppenheimer; BMO Capital Markets; and Ladenburg Thalmann are underwriters. ADMA proposed to raise up to $34.5 million in an IPO in February after becoming a publicly reporting company via the Form 10 pathway last year (see BioCentury, Feb. 20, 2012). ...